What is Bio-Rad Laboratories, Inc.'s all other segments — D&A?

Bio-Rad Laboratories, Inc. (BIO.B) reported all other segments — D&A of $0 in Q4 2025.

What does all other segments — D&A mean?

Represents the systematic allocation of the cost of tangible and intangible assets associated with the 'All Other Segments' over their useful lives. This non-cash expense reflects the wear and tear or obsolescence of assets used in these specific business activities. It is a key component in reconciling net income to cash flow for these segments.

Bio-Rad Laboratories, Inc. BIO.B All Other Segments — D&A

Discontinued — last reported Q4 '25

Other segment segments

Clinical Diagnostics

$22.6M+7.1%

Life Science

$18.3M+7.6%

Similar metrics at other companies

OGEAll Other Segments — D&A

$0—

CTASAll Other Segments — D&A

$7.27M+27.6%

YUMCAll Other Segments — D&A

$2M0.0%

SLBAll Other Segments — D&A

$84M-24.3%

AEPAll Other Segments — D&A

$225K+12.5%

CATAll Other Segment — D&A

$68M+7.9%

Other financials

Income statement

See full

Revenue$592.1M+1.1%

Gross profit$309.4M+1.1%

Operating income$34.1M+43.9%

Net income-$527.1M-924%

EPS (diluted)-$19.55-954%

Balance sheet

See full

Cash & equivalents$509.0M-2.7%

Total debt$987.3M-28.4%

Total equity$6.9B+2.6%

Total assets$9.8B+2.8%

Cash flow

See full

Operating cash flow$108.1M-16.8%

CapEx$30.0M-12.8%

Free cash flow$78.1M-18.2%

Valuation

See full

Market cap$7.56B+10.3%

Enterprise value$8.04B+4.2%

P/E44.8×—

P/S2.9×+0.2×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin8.8%-3.1pp

Net margin6.5%+3.4pp

FCF margin13.8%-0.2pp

Returns & leverage

See full

Return on equity2.5%+1.3pp

Debt / equity0.1×-0.1×

Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Bio-Rad Laboratories, Inc.’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s all other segments — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s all other segments — D&A?: Bio-Rad Laboratories, Inc. (BIO.B) reported all other segments — D&A of $0 in Q4 2025.
What does all other segments — D&A mean?: Represents the systematic allocation of the cost of tangible and intangible assets associated with the 'All Other Segments' over their useful lives. This non-cash expense reflects the wear and tear or obsolescence of assets used in these specific business activities. It is a key component in reconciling net income to cash flow for these segments.